Bigul

Kilitch Drugs India Ltd - 524500 - Closure of Trading Window

With reference to the above subject, this is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with NSE Circular Reference no. NSE/CML/2019/11 and BSE Circular Reference no. LIST/COMP/01/2019-20, both dated April 02, 2019 Trading Window for dealing in Securities of the Company will remain closed for all Directors, Officers, Designated Persons of the Company and their immediate relatives with effect from Thursday, April 04, 2019 till 48 hours after the declaration of Audited Financial Results of the Company for the quarter and year ended March 31, 2019.
04-04-2019
Bigul

Kilitch Drugs India Ltd - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
27-03-2019
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
19-03-2019
Bigul

Kilitch Drugs India Ltd - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
15-03-2019
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
08-03-2019
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

We are pleased to enclosed herewith our Press Release relating to Financial Results for quarter & nine months ended 31st December 2018.
12-02-2019
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Outcome of Board Meeting

Outcome of Board Meeting held on February 12, 2019
12-02-2019
Bigul

Kilitch Drugs India Ltd - 524500 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Conference Call for Q3 & 9M FY19 Earnings to be held on Tuesday, February 12, 2019 at 5.00 P.M.(IST)
11-02-2019
Bigul

Kilitch Drugs India Ltd - 524500 - Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter Ended December 31, 2018 And To Consider The Appointment Of CA Sujit Kumar Dash As A Chief Financial Officer Of The Company.

KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019 ,inter alia, to consider and approve 1.To consider and approve the un-audited financial results of the company for the quarter ended December 31, 2018. 2.To consider the resignation of Mr. Shailesh Mirgal as a Chief Financial Officer of the Company. 3.To consider the appointment of CA Sujit Kumar Dash as a Chief Financial Officer of the Company. 4.To consider the appointment of M/s. Deep Shukla & Associates, Company Secretaries to conduct Secretarial Audit of the Company for financial year ended 31st March, 2019. 5.Any other matter with the permission of the chair.
05-02-2019
Bigul

Kilitch Drugs India Ltd - 524500 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

This is to inform you that Mr. Shailesh Mirgal has resigned from the post of Chief Financial Officer of the Company w.e.f. 4th February , 2019.
04-02-2019
Next Page
Close

Let's Open Free Demat Account